Phyllodes Tumor is NOT Breast Cancer
Phyllodes tumor (formerly called cystosarcoma phyllodes) is not a form of breast cancer—it is a distinct fibroepithelial neoplasm of the breast that is managed fundamentally differently from epithelial breast cancers. 1
Key Distinguishing Features
Tumor Classification
Phyllodes tumors are rare tumors consisting of both stromal and epithelial elements, not epithelial carcinomas 1. They exist in three subtypes:
- Benign
- Borderline
- Malignant
This classification is based on stromal characteristics, not epithelial malignancy 1.
Critical Management Differences from Breast Cancer
Axillary lymph node management:
- No sentinel lymph node biopsy or axillary dissection is required for phyllodes tumors, even malignant subtypes 1, 2
- Axillary staging is only necessary if lymph nodes are clinically pathologic on examination 1
- This contrasts sharply with invasive breast cancer where axillary staging is standard
Systemic therapy:
- Endocrine therapy has no proven role, despite 58% being ER-positive and 75% being PR-positive 1
- Adjuvant chemotherapy does not reduce recurrence or death rates 1
- This is fundamentally different from hormone receptor-positive breast cancers where endocrine therapy is cornerstone treatment
Metastatic disease management:
- When systemic recurrence occurs (rare, usually pulmonary), treatment follows soft tissue sarcoma guidelines, not breast cancer protocols 1
Important Clinical Pitfall
The term "cystosarcoma phyllodes" is misleading and outdated—the "sarcoma" designation does not mean it behaves like typical breast cancer 3. The UK guidelines explicitly state that breast tumors with sarcomatous differentiation within a metaplastic carcinoma should be managed as epithelial breast tumors (triple-negative breast cancers), not as phyllodes tumors 2. This distinction is critical to avoid mismanagement.
Surgical Approach
Treatment is wide local excision with 1 cm margins for all subtypes (benign, borderline, malignant) 1. Mastectomy is only required when adequate margins cannot be achieved with breast-conserving surgery 1. The margin status is more important than histologic subtype for predicting local recurrence 1.
Referral Patterns
Due to their distinct biology, borderline and malignant phyllodes tumors should be referred to specialist sarcoma centers for pathology review and multidisciplinary team discussion, not managed solely by breast cancer teams 2.